 1 Clinically important pulmonary disease other than asthma. 2 History of anaphylaxis following any biologic therapy. 3 Hepatitis B, C or HIV. 4 Pregnant or breastfeeding. 5 History of cancer. 6 Current tobacco smoking or a history of tobacco smoking for 10 pack-years. 7 Previous receipt of tralokinumab. 